Daniel Myran on the risk of developing an anxiety disorder following an emergency department visit due to cannabis use

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/c4/45/1b/c4451be5-4daa-1dda-abc1-9ad2ada74fc0/mza_9041289620623617024.jpg/600x600bb.jpg

eClinicalMedicine in conversation with

The Lancet Group

42 episodes

2 weeks ago

Giulia Zamagni joins Claudia Schaefer to discuss her recent Series of 4 papers from the Italian Global Burden of Disease collaborators providing the disease burden estimates and temporal trends for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy. Click here to read the full text in this series: paper 1; paper 2; paper 3; paper 4 Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup...

All content for eClinicalMedicine in conversation with is the property of The Lancet Group and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Daniel Myran on the risk of developing an anxiety disorder following an emergency department visit due to cannabis use

eClinicalMedicine in conversation with

15 minutes

1 year ago

Daniel Myran on the risk of developing an anxiety disorder following an emergency department visit due to cannabis use

Daniel Myran joins Hannah Linne, Senior Editor at eClinicalMedicine, to discuss the findings of their recent population-based cohort study investigating the risk of having an incident healthcare visit for an anxiety disorder following an emergency department visit for cannabis use.Read the full article:https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00034-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_eclinmContinue this conversation on social!Follow us today at...https://...